Advanced Analysis of DNA and RNA for Clinical Insight:
Molecular diagnostics involves detecting and analysing DNA or RNA to provide meaningful clinical information. This rapidly growing field offers insights that traditional laboratory techniques cannot, enabling earlier, more precise detection of disease processes.

Pathogen Detection and Quantitative Monitoring:
Molecular testing allows for the rapid identification and viral/bacterial load monitoring of infectious agents. This is essential for managing diseases such as HIV, hepatitis, tuberculosis, respiratory infections, and emerging pathogens.

Genetic Testing for Inherited Conditions:
Molecular assays are used to detect hereditary genetic abnormalities, carrier states, and mutations associated with inherited disorders. These tests assist in diagnosis, family counselling, early interventions, and long-term clinical planning.

Somatic Testing for Tumour Prognostication and Therapy Guidance:
Tumour DNA and RNA can be analysed to identify actionable mutations, predict disease behaviour, and guide targeted cancer therapy. This includes assessing treatment responsiveness, identifying resistance patterns, and informing personalised oncology strategies.

Extensive and Evolving Molecular Test Menu:
FlowPath Labs offers a broad and continually expanding range of molecular diagnostics. Ongoing investment in cutting-edge technology, staff development, and collaboration with internationally accredited laboratories ensures accurate results, rapid turnaround times, and expert interpretation and advice.

Modern Diagnostic Approach with Significant Patient Benefit:
Although newer than conventional chemistry or microbiology methods, molecular diagnostics has quickly become indispensable. Its high sensitivity and specificity support improved diagnosis, targeted treatment, and personalised patient care.